Common Rule Delayed Another Six Months in HHS Final Rule

International Pharmaceutical Regulatory Monitor
A A
HHS issued a final rule to once again delay implementation of the revised Common Rule on the protection of human subjects in clinical trials for six months until Jan. 21, 2019, and to permit an exception from the existing federal policy for three burden-reducing provisions during the delay period.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor